Processing of an antigenic sequence from IgG constant domains for presentation by MHC class II

Journal of Immunology

Volumn 181, Issue 10, 2008, Pages 7062-7072

  Flobakk, Morten ^a,c   Rasmussen, Ingunn B ^a   Lunde, Elin ^a   Frigstad, Terje ^a   Berntzen, Gøril ^a   Michaelsen, Terje E ^b   Bogen, Bjarne ^a   Sandlie, Inger ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^c BioInn   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; EPITOPE; HLA ANTIGEN CLASS 2; HYBRID PROTEIN;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIGEN PRESENTATION; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYBRIDOMA; IN VITRO STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOGLOBULIN CONSTANT REGION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; PROTEIN SECONDARY STRUCTURE; SYNTHESIS;

ANIMALS; ANTIGEN PRESENTATION; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES, T-LYMPHOCYTE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNOGLOBULIN CONSTANT REGIONS; IMMUNOGLOBULIN G; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; PROTEIN STRUCTURE, SECONDARY; RECOMBINANT FUSION PROTEINS;

EID: 58149179179     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.10.7062     Document Type: Article

References (62)

1. Snider, D. P., and D. M. Segal. 1987. Targeted antigen presentation using cross-linked antibody heteroaggregates. J. Immunol. 139: 1609-1616.
2. Bona, C. A., S. Casares, and T. D. Brumeanu. 1998. Towards development of T-cell vaccines. Immunol. Today 19: 126-133.
3. Baier, G., G. Baier-Bitterlich, D. J. Looney, and A. Altman. 1995. Immunogenic targeting of recombinant peptide vaccines to human antigen- presenting cells by chimeric anti-HLA-DR and anti-surface immunoglobulin D antibody Fab fragments in vitro. J. Virol. 69: 2357-2365.
4. Hawiger, D., K. Inaba, Y. Dorsett, M. Guo, K. Mahnke, M. Rivera, J. V. Ravetch, R. M. Steinman, and M. C. Nussenzweig. 2001. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194: 769-779. (Pubitemid 32983013)
5. + T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine. J. Exp. Med. 203: 607-617.
6. Bogen, B., and J. D. Lambris. 1989. Minimum length of an idiotypic peptide and a model for its binding to a major histocompatibility complex class II molecule. EMBO J. 8: 1947-1952. (Pubitemid 19273519)
7. Bogen, B., B. Malissen, and W. Haas. 1986. Idiotope-specific T cell clones that recognize syngeneic immunoglobulin fragments in the context of class II molecules. Eur. J. Immunol. 16: 1373-1378. (Pubitemid 17206155)
8. Lunde, E., B. Bogen, and I. Sandlie. 1997. Immunoglobulin as a vehicle for foreign antigenic peptides immunogenic to T cells. Mol. Immunol. 34: 1167-1176. (Pubitemid 28179150)
9. Eidem, J. K., I. B. Rasmussen, E. Lunde, T. F. Gregers, A. R. Rees, B. Bogen, and I. Sandlie. 2000. Recombinant antibodies as carrier proteins for sub-unit vaccines: influence of mode of fusion on protein production and T-cell activation. J. Immunol. Methods 245: 119-131.
10. Rasmussen, I. B., E. Lunde, T. E. Michaelsen, B. Bogen, and I. Sandlie. 2001. The principle of delivery of T cell epitopes to antigen-presenting cells applied to peptides from influenza virus, ovalbumin, and hen egg lysozyme: implications for peptide vaccination. Proc. Natl. Acad. Sci. USA 98: 10296-10301.
11. Lunde, E., L. A. Munthe, A. Vabo, I. Sandlie, and B. Bogen. 1999. Antibodies engineered with IgD specificity efficiently deliver integrated T-cell epitopes for antigen presentation by B cells. Nat. Biotechnol. 17: 670-675. (Pubitemid 29316145)
12. Lunde, E., K. H. Western, I. B. Rasmussen, I. Sandlie, and B. Bogen. 2002. Efficient delivery of T cell epitopes to APC by use of MHC class II-specific Troy bodies. J. Immunol. 168: 2154-2162. (Pubitemid 34171814)
13. Tisch, R., M. Watanabe, M. Letarte, and N. Hozumi. 1987. Assessment of antigen-specific receptor function of surface immunoglobulin M and D with identical hapten specificity. Proc. Natl. Acad. Sci. USA 84: 3831-3835. (Pubitemid 17088373)
14. Bogen, B., L. Gleditsch, S. Weiss, and Z. Dembic. 1992. Weak positive selection of transgenic T cell receptor-bearing thymocytes: importance of major histocompatibility complex class II, T cell receptor and CD4 surface molecule densities. Eur. J. Immunol. 22: 703-709.
15. White, J., M. Blackman, J. Bill, J. Kappler, P. Marrack, D. P. Gold, and W. Born. 1989. Two better cell lines for making hybridomas expressing specific T cell receptors. J. Immunol. 143: 1822-1825. (Pubitemid 19241193)
16. Prat, M., G. Gribaudo, P. M. Comoglio, G. Cavallo, and S. Landolfo. 1984. Monoclonal antibodies against murine γ interferon. Proc. Natl. Acad. Sci. USA 81: 4515-4519. (Pubitemid 14055922)
17. Cherwinski, H. M., J. H. Schumacher, K. D. Brown, and T. R. Mosmann. 1987. Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J. Exp. Med. 166: 1229-1244.
18. 2 and Fab′ fragments relative to immunoglobulin G in reactions with surface-bound antigens. Eur. J. Nucl. Med. 19: 402-408.
19. Jefferis, R., C. B. Reimer, F. Skvaril, G. de Lange, N. R. Ling, J. Lowe, M. R. Walker, D. J. Phillips, C. H. Aloisio, T. W. Wells, et al. 1985. Evaluation of monoclonal antibodies having specificity for human IgG sub-classes: results of an IUIS/WHO collaborative study. Immunol. Lett. 10: 223-252.
20. Aaberge, I. S., T. E. Michaelsen, A. K. Rolstad, E. C. Groeng, P. Solberg, and M. Lovik. 1992. SCID-Hu mice immunized with a pneumococcal vaccine produce specific human antibodies and show increased resistance to infection. Infect. Immun. 60: 4146-4153.
21. Michaelsen, T. E., A. Aase, C. Westby, and I. Sandlie. 1990. Enhancement of complement activation and cytolysis of human IgG3 by deletion of hinge exons. Scand. J. Immunol. 32: 517-528.
22. Berman, H. M., J. Westbrook, Z. Feng, G. Gilliland, T. N. Bhat, H. Weissig, I. N. Shindyalov, and P. E. Bourne. 2000. The Protein Data Bank. Nucleic Acids Res. 28: 235-242.
23. Saphire, E. O., R. L. Stanfield, M. D. Crispin, G. Morris, M. B. Zwick, R. A. Pantophlet, P. W. Parren, P. M. Rudd, R. A. Dwek, D. R. Burton, and I. A. Wilson. 2003. Crystal structure of an intact human IgG: antibody asymmetry, flexibility, and a guide for HIV-1 vaccine design. Adv. Exp. Med. Biol. 535: 55-66.
24. Gasteiger, E., C. Hoogland, A. Gattiker, S. Duvaud, M. R. Wilkins, R. D. Appel, and A. Bairoch. 2005. Protein identification and analysis tools on the ExPASy. In The Proteomics Protocols Handbook. John M. Walker, ed. Humana Press, Totowa, NJ, pp. 571-607.
25. Kyte, J., and R. F. Doolittle. 1982. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157: 105-132.
26. Huck, S., P. Fort, D. H. Crawford, M. P. Lefranc, and G. Lefranc. 1986. Sequence of a human immunoglobulin γ 3 heavy chain constant region gene: comparison with the other human C γ genes. Nucleic Acids Res. 14: 1779-1789. (Pubitemid 16145781)
27. Norderhaug, L., T. Olafsen, T. E. Michaelsen, and I. Sandlie. 1997. Versatile vectors for transient and stable expression of recombinant antibody molecules in mammalian cells. J. Immunol. Methods 204: 77-87. (Pubitemid 27192314)
28. Berntzen, G., E. Lunde, M. Flobakk, J. T. Andersen, V. Lauvrak, and I. Sandlie. 2005. Prolonged and increased expression of soluble Fc receptors, IgG and a TCR-Ig fusion protein by transiently transfected adherent 293E cells. J. Immunol. Methods 298: 93-104. (Pubitemid 40545096)
29. Berntzen, G., O. H. Brekke, S. A. Mousavi, J. T. Andersen, T. E. Michaelsen, T. Berg, I. Sandlie, and V. Lauvrak. 2006. Characterization of an FcγRI-binding peptide selected by phage display. Protein Eng. Des. Sel. 19: 121-128.
30. d molecules, a haplotype of the BALB/c mouse. Nucleic Acids Res. 33: W180-W183.
31. Schild, H., U. Gruneberg, G. Pougialis, H. J. Wallny, W. Keilholz, S. Stevanovic, and H. G. Rammensee. 1995. Natural ligand motifs of H-2E molecules are allele specific and illustrate homology to HLA-DR molecules. Int. Immunol. 7: 1957-1965. (Pubitemid 26003702)
32. Ellgaard, L., and A. Helenius. 2003. Quality control in the endoplasmic reticulum. Nat. Rev. Mol. Cell Biol. 4: 181-191.
33. Bothwell, A. L., M. Paskind, M. Reth, T. Imanishi-Kari, K. Rajewsky, and D. Baltimore. 1982. Somatic variants of murine immunoglobulin λ light chains. Nature 298: 380-382.
34. Rothlisberger, D., A. Honegger, and A. Pluckthun. 2005. Domain interactions in the Fab fragment: a comparative evaluation of the single-chain Fv and Fab format engineered with variable domains of different stability. J. Mol. Biol. 347: 773-789. (Pubitemid 40357919)
35. Lesk, A. M., and C. Chothia. 1988. Elbow motion in the immunoglobulins involves a molecular ball-and-socket joint. Nature 335: 188-190.
36. Kim, J. K., M. Firan, C. G. Radu, C. H. Kim, V. Ghetie, and E. S. Ward. 1999. Mapping the site on human IgG for binding of the MHC class I-related receptor, FcRn. Eur. J. Immunol. 29: 2819-2825.
37. Sondermann, P., R. Huber, V. Oosthuizen, and U. Jacob. 2000. The 3.2-Å crystal structure of the human IgG1 Fc fragment-Fc γRIII complex. Nature 406: 267-273. (Pubitemid 30604397)
38. Idusogie, E. E., L. G. Presta, H. Gazzano-Santoro, K. Totpal, P. Y. Wong, M. Ultsch, Y. G. Meng, and M. G. Mulkerrin. 2000. Mapping of the C1q binding site on rituxan, a chimeric antibody with a human IgG1 Fc. J. Immunol. 164: 4178-4184.
39. Nezlin, R., and V. Ghetie. 2004. Interactions of immunoglobulins outside the antigen-combining site. Adv. Immunol. 82: 155-215. (Pubitemid 38209511)
40. Ewert, S., A. Honegger, and A. Pluckthun. 2003. Structure-based improvement of the biophysical properties of immunoglobulin VH domains with a generalizable approach. Biochemistry 42: 1517-1528. (Pubitemid 36205958)
41. Dall'Acqua, W., A. L. Simon, M. G. Mulkerrin, and P. Carter. 1998. Contribution of domain interface residues to the stability of antibody CH3 domain homodimers. Biochemistry 37: 9266-9273. (Pubitemid 28307680)
42. Tunheim, G., K. W. Schjetne, I. B. Rasmussen, L. M. Sollid, I. Sandlie, and B. Bogen. 2008. Recombinant antibodies for delivery of antigen: a single loop between β-strands in the constant region can accommodate long, complex and tandem T cell epitopes. Int. Immunol. 20: 295-306. (Pubitemid 351321237)
43. Thai, R., G. Moine, M. Desmadril, D. Servent, J. L. Tarride, A. Menez, and M. Leonetti. 2004. Antigen stability controls antigen presentation. J. Biol. Chem. 279: 50257-50266.
44. So, T., H. O. Ito, T. Koga, S. Watanabe, T. Ueda, and T. Imoto. 1997. Depression of T-cell epitope generation by stabilizing hen lysozyme. J. Biol. Chem. 272: 32136-32140. (Pubitemid 28011886)
45. Chen, J. M., P. M. Dando, N. D. Rawlings, M. A. Brown, N. E. Young, R. A. Stevens, E. Hewitt, C. Watts, and A. J. Barrett. 1997. Cloning, isolation, and characterization of mammalian legumain, an asparaginyl endopeptidase. J. Biol. Chem. 272: 8090-8098.
46. Manoury, B., E. W. Hewitt, N. Morrice, P. M. Dando, A. J. Barrett, and C. Watts. 1998. An asparaginyl endopeptidase processes a microbial antigen for class II MHC presentation. Nature 396: 695-699. (Pubitemid 29003950)
47. Finkelman, F. D., I. Scher, J. J. Mond, S. Kessler, J. T. Kung, and E. S. Metcalf. 1982. Polyclonal activation of the murine immune system by an antibody to IgD: II. Generation of polyclonal antibody production and cells with surface IgG. J. Immunol. 129: 638-646. (Pubitemid 12039389)
48. Yan, J., M. J. Wolff, J. Unternaehrer, I. Mellman, and M. J. Mamula. 2005. Targeting antigen to CD19 on B cells efficiently activates T cells. Int. Immunol. 17: 869-877. (Pubitemid 41417954)
49. Casten, L. A., and S. K. Pierce. 1988. Receptor-mediated B cell antigen processing: increased antigenicity of a globular protein covalently coupled to antibodies specific for B cell surface structures. J. Immunol. 140: 404-410.
50. Tunheim, G., K. W. Schjetne, A. B. Fredriksen, I. Sandlie, and B. Bogen. 2005. Human CD14 is an efficient target for recombinant immunoglobulin vaccine constructs that deliver T cell epitopes. J. Leukocyte Biol. 77: 303-310. (Pubitemid 40289559)
51. Tillman, B. W., T. D. de Gruijl, S. A. Luykx-de Bakker, R. J. Scheper, H. M. Pinedo, T. J. Curiel, W. R. Gerritsen, and D. T. Curiel. 1999. Maturation of dendritic cells accompanies high-efficiency gene transfer by a CD40-targeted adenoviral vector. J. Immunol. 162: 6378-6383.
52. Schjetne, K. W., A. B. Fredriksen, and B. Bogen. 2007. Delivery of antigen to CD40 induces protective immune responses against tumors. J. Immunol. 178: 4169-4176.
53. + T cells and could be an efficient vaccine target. J. Immunol. 171: 32-36.
54. Jackson, D. C., Y. F. Lau, T. Le, A. Suhrbier, G. Deliyannis, C. Cheers, C. Smith, W. Zeng, and L. E. Brown. 2004. A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses. Proc. Natl. Acad. Sci. USA 101: 15440-15445.
55. + blood dendritic cells: characterization of the APC that functions to enhance adaptive immune responses against CD91-targeted antigens. J. Immunol. 172: 70-78.
56. + T cell responses. Eur. J. Immunol. 33: 3101-3108.
57. Biragyn, A., K. Tani, M. C. Grimm, S. Weeks, and L. W. Kwak. 1999. Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity. Nat. Biotechnol. 17: 253-258. (Pubitemid 29122633)
58. Schjetne, K. W., K. M. Thompson, T. Aarvak, B. Fleckenstein, L. M. Sollid, and B. Bogen. 2002. A mouse C κ-specific T cell clone indicates that DC-SIGN is an efficient target for antibody-mediated delivery of T cell epitopes for MHC class II presentation. Int. Immunol. 14: 1423-1430.
59. Tacken, P. J., I. J. de Vries, K. Gijzen, B. Joosten, D. Wu, R. P. Rother, S. J. Faas, C. J. Punt, R. Torensma, G. J. Adema, and C. G. Figdor. 2005. Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody. Blood 106: 1278-1285.
60. He, L. Z., V. Ramakrishna, J. E. Connolly, X. T. Wang, P. A. Smith, C. L. Jones, M. Valkova-Valchanova, A. Arunakumari, J. F. Treml, J. Goldstein, et al. 2004. A novel human cancer vaccine elicits cellular responses to the tumor-associated antigen, human chorionic gonadotropin β. Clin. Cancer Res. 10: 1920-1927.
61. Mahnke, K., Y. Qian, S. Fondel, J. Brueck, C. Becker, and A. H. Enk. 2005. Targeting of antigens to activated dendritic cells in vivo cures metastatic melanoma in mice. Cancer Res. 65: 7007-7012. (Pubitemid 41060741)
62. Bonifaz, L. C., D. P. Bonnyay, A. Charalambous, D. I. Darguste, S. Fujii, H. Soares, M. K. Brimnes, B. Moltedo, T. M. Moran, and R. M. Steinman. 2004. In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J. Exp. Med. 199: 815-824.